Agomab Therapeutics NV

For the period ended Aug 10, 2026. Filed Aug 10, 2026.

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Aug 10, 2026 · Filed Aug 10, 2026

Use the contents to explore the available documents and sections.

AGMB$7.64+9.5%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.2 · Availability of documents

Availability of documents

In preparation for the general meeting, please consult the documents listed below, which are attached hereto and available on the Company’s website (https://ir.agomab.com/governance/shareholder-meetings).

1.	Professional biography of Mr. Marino Garcia

2.	Professional biography of Dr. Naimish Patel

3.	Proxy form;

4.	Voting form.

Prior to the general meeting, the Company’s holders of securities may also obtain a copy of the aforementioned documentation free of charge at the Company’s registered office (Posthoflei 1, Box 6, 2600 Antwerp (Berchem), Belgium).

Sincerely, on behalf of the Board of Directors

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.